Author

Nael M. Mostafa 1

1 AbbVie Inc.

High versus standard adalimumab induction dosing regimens in patients with moderately to severely active ulcerative colitis: results from the SERENE-UC induction study

Julian Panés, Jean-Frederic Colombel, Geert R. D'Haens, Stefan Schreiber, Remo Panaccione, Laurent Peyrin-Biroulet, Edward Loftus, Jr, Silvio Danese, Edouard Louis, Alessandro Armuzzi, Marc Ferrante, Harald Vogelsang, Jessica Lefebvre, Thao Doan, Nisha V. Kwatra, Nael M. Mostafa, Wangang Xie, Bidan Huang, Joel Petersson;;

EXPOSURE-EFFICACY RELATIONSHIP (ER) FOR ADALIMUMAB DURING INDUCTION PHASE OF TREATMENT OF ADULT PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS (UC)

Nael M. Mostafa, Doerthe Eckert, Rajendra S Pradhan, Sven Mensing, Anne M. Robinson, Stephen B Hanauer, Jean-Frederic Colombel, Roopal B Thakkar, Walid Awni, William Sandborn

ADALILMUMAB SERUM CONCENTRATION AS A PREDICTOR FOR CLINICAL EFFICACY - ROC ANALYSES

Nael M. Mostafa, Anne M. Robinson, Shringi Sharma, William Sandborn, Subrata Ghosh, Stephen B Hanauer, Roopal B Thakkar, Walid Awni

High versus standard adalimumab induction dosing regimens in patients with moderately to severely active Crohn's disease: Results from the SERENE-CD induction study

Geert D‘Haens, William Sandborn, Edward Loftus, Jr, Stephen B Hanauer, Stefan Schreiber, Laurent Peyrin-Biroulet, Remo Panaccione, Julian Panés, Jean-Frederic Colombel, Marc Ferrante, Edouard Louis, Alessandro Armuzzi, Qian Zhou, Bidan Huang, Nisha V. Kwatra, Nael M. Mostafa, Thao Doan, Joel Petersson, Alex Song, Anne M.

Item 1 - 4 / 4
1